Back
Speaker illustration

undefined undefined undefined

Presentations

Has post-COVID-19 increased CTEPD rates? A prospective study on persistent dyspnea and risk factors

Event: ESC Congress 2025

Topic: Pulmonary Hypertension

Session: Venous thromboembolism

Access
Like
Thumbnail

Impact of medical therapy on balloon pulmonary angioplasty outcomes in chronic thromboembolic pulmonary hypertension

Event: ESC Congress 2025

Topic: Pulmonary Hypertension

Session: Chronic thromboembolic pulmonary hypertension: management strategies

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources